Don’t Miss TipRanks’ Half-Year Sale
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
- Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.
The latest announcement is out from CERo Therapeutics Holdings ( (CERO) ).
CERo Therapeutics Holdings recently engaged in a private placement offering, selling shares of its Series D Preferred Stock, which are convertible into common stock. On June 25, 2025, the company completed an additional closing, raising approximately $1,852,000 from the sale of 2,315 shares. This transaction was conducted without registration under the Securities Act, relying on exemptions for sales to accredited investors, potentially impacting the company’s capital structure and financial flexibility.
The most recent analyst rating on (CERO) stock is a Buy with a $3.00 price target. To see the full list of analyst forecasts on CERo Therapeutics Holdings stock, see the CERO Stock Forecast page.
More about CERo Therapeutics Holdings
Average Trading Volume: 1,161,738
Technical Sentiment Signal: Sell
Current Market Cap: $4.93M
For a thorough assessment of CERO stock, go to TipRanks’ Stock Analysis page.